Catch up on the top pharma news stories from August in our monthly round-up. From the latest on the spread of mpox to new treatment approvals, there’s plenty to discover.

We look at the latest examples of how pharma and its partners are working together to develop technology to solve key healthcare challenges.

Vasculogenic female sexual dysfunction syndromes affect millions of ageing women worldwide, whose day-to-day symptoms of coital…

A new study involving 124,545 MS patients reveals that COVID-19 vaccination does not significantly increase relapse risk, except in those with highly active, untreated MS.

A new study found a significant link between chemotherapy-induced disruptions in the gut microbiome and cognitive decline in female patients with breast cancer.

Roche has secured European Commission approval for its drug crovalimab, marking a significant advancement in the treatment of PNH.

Developmental and epileptic encephalopathy (DEE) refers to a collection of rare and severe epilepsies that feature both seizures and…

A RECENT study has found a link between alcohol consumption and the risk of developing gout.

Recent studies suggest liver stiffness as the primary indicator for assessing long-term risk after Hepatitis C virus treatment